Skip to main content
. Author manuscript; available in PMC: 2011 Sep 8.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Apr 20;19(5):1356–1361. doi: 10.1158/1055-9965.EPI-09-1151

Table 2.

Tag-SNPs associated with risk of meningioma at p-trend<0.01 in hospital-based case-control study of meningioma, National Cancer Institute Adult Brain Tumor Study, 1994–1998

Region Gene SNP ID Genotype Control n (%) Case n (%) Odds Ratio (OR) (95% CI)
NFKB1
 NFKB1 rs230540 TT 126 (38.3) 49 (48.5) 1.00
CT 162 (49.2) 48 (47.5) 0.67 (0.41 – 1.11)
CC 41 (12.5) 4 (4.0) 0.16 (0.05 – 0.51)
Ptrend 0.001
rs3755867 AA 140 (42.4) 52 (51.5) 1.00
AG 156 (47.3) 47 (46.5) 0.74 (0.45 – 1.22)
GG 34 (10.3) 2 (2.0) 0.11 (0.02 – 0.48)
Ptrend 0.002
rs1585213 CC 117 (35.6) 42 (41.6) 1.00
CT 164 (49.9) 55 (54.5) 0.86 (0.52 – 1.42)
TT 48 (14.6) 4 (4.0) 0.16 (0.05 – 0.50)
Ptrend 0.004
VCAM1
 VCAM1 rs2209627 AA 222 (67.7) 54 (53.5) 1.00
AG 92 (28.1) 41 (40.6) 2.60 (1.53 – 4.42)
GG 14 (4.3) 6 (5.9) 2.13 (0.66 – 6.80)
Ptrend 0.001
FCER1G
 NDUFS2 rs4656993 GG 116 (35.3) 21 (20.8) 1.00
AG 155 (47.1) 50 (49.5) 1.98 (1.08 – 3.61)
AA 58 (17.6) 30 (29.7) 2.92 (1.45 – 5.87)
Ptrend 0.002
 FCER1G rs12094497 GG 270 (82.1) 93 (92.1) 1.00
AG 52 (15.8) 8 (7.9) 0.34 (0.17 – 0.87)
AA 7 (2.1) 0 (0.0) 0.00 0 |
Ptrend 0.004
rs11587213 AA 224 (67.9) 80 (80.0) 1.00
AG 93 (28.2) 19 (19.0) 0.53 (0.29 – 0.96)
GG 13 (3.9) 1 (1.0) 0.20 (0.02 – 1.72)
Ptrend 0.008
CD14
 PRO1580 rs3822356 AA 208 (63.4) 49 (48.5) 1.00
1.09
AG (33.2) 47 (46.5) 2.24 (1.34 – 3.76)
GG 11 (3.4) 5 (5.0) 2.15 (0.65 – 7.14)
Ptrend 0.003
TNFRSF18
 TNFRSF18 rs9729550 AA 180 (54.9) 68 (67.3) 1.00
AC 121 (36.9) 29 (28.7) 0.56 (0.33 – 0.95)
CC 27 (8.2) 4 (4.0) 0.28 (0.09 – 0.89)
Ptrend 0.003
RAC2
 RAC2 rs2213430 CC 103 (31.2) 38 (37.6) 1.00
CT 165 (50.0) 49 (48.5) 0.56 (0.32 – 0.96)
TT 62 (18.8) 14 (13.9) 0.35 (0.16 – 0.75)
Ptrend 0.004
XDH
 XDH rs207444 GG 291 (88.5) 97 (96.0) 1.00
AG 37 (11.3) 4 (4.0) 0.26 (0.09 – 0.79)
AA 1 (0.3) 0 (0.0) 0.00 0 |
Ptrend 0.005
C1D
 C1D rs10203061 AA 235 (71.7) 56 (56.0) 1.00
AG 85 (25.9) 40 (40.0) 1.98 (1.18 – 3.33)
GG 8 (2.4) 4 (4.0) 2.81 (0.70 – 11.2)
Ptrend 0.006
CCR6
 CCR6 rs9459883 GG 265 (80.3) 91 (90.1) 1.00
CG 63 (19.1) 10 (9.9) 0.42 (0.20 – 0.89)
CC 2 (0.6) 0 (0.0) 0.00 0 |
Ptrend 0.008
rs3798315 CC 251 (76.1) 87 (86.1) 1.00
CT 72 (21.8) 13 (12.9) 0.43 (0.21 – 0.87)
TT 7 (2.1) 1 (1.0) 0.31 (0.03 – 2.81)
Ptrend 0.008
TLR1/TLR10/TLR6
 TLR10 rs11466657 AA 306 (93.9) 97 (98.0) 1.00
AG 20 (6.1) 2(2.0) 0.19 (0.04 – 0.84)
GG -- --
Ptrend 0.008
NOS1
 NOS1 rs10850803 AA 273 (83.2) 73 (72.3) 1.00
AG 54 (16.5) 24 (23.8) 1.70 (0.92 – 3.13)
GG 1 (0.3) 4 (4.0) 13.50 (1.16 – 157)
Ptrend 0.009
DEFA5
 DEFA5 rs10503360 TT 95 (28.8) 13 (12.9) 1.00
GT 160 (48.5) 56 (55.5) 2.10 (1.05 – 4.19)
GG 75 (22.7) 32 (31.7) 2.74 (1.28 – 5.83)
Ptrend 0.01
1

Odds ratios adjusted for sex, age, study hospital, and distance of residence from hospital.